| Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo … A Lotery, S Sivaprasad, A O'Connell, RA Harris, L Culliford, L Ellis, A Cree, ... The Lancet 395 (10220), 294-303, 2020 | 193 | 2020 |
| Non-infectious uveitis: optimising the therapeutic response A Airody, G Heath, S Lightman, R Gale Drugs 76, 27-39, 2016 | 46 | 2016 |
| Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review RLW Hanson, A Airody, S Sivaprasad, RP Gale Eye 37 (12), 2438-2453, 2023 | 29 | 2023 |
| Following the status of visual cortex over time in patients with macular degeneration reveals atrophy of visually deprived brain regions RLW Hanson, RP Gale, AD Gouws, A Airody, MTW Scott, F Akthar, ... Investigative ophthalmology & visual science 60 (15), 5045-5051, 2019 | 26 | 2019 |
| The ocular manifestations of drugs used to treat multiple sclerosis G Heath, A Airody, RP Gale Drugs 77 (3), 303-311, 2017 | 15 | 2017 |
| Clinical characteristics and outcomes after 5 years pro re nata treatment of neovascular age‐related macular degeneration with ranibizumab A Airody, D Venugopal, V Allgar, RP Gale Acta ophthalmologica 93 (6), e511-e512, 2015 | 12 | 2015 |
| Improved Structure and Function in Early-Detected Second-Eye Neovascular Age-Related Macular Degeneration: FASBAT/Early Detection of Neovascular Age-Related Macular … RP Gale, A Airody, S Sivaprasad, RLW Hanson, V Allgar, M McKibbin, ... Ophthalmology Retina 8 (6), 545-552, 2024 | 4 | 2024 |
| Cortical atrophy predicts visual performance in long-term central retinal disease; GCL, pRNFL and cortical thickness are key biomarkers RLW Hanson, HA Baseler, A Airody, AB Morland, RP Gale Investigative ophthalmology & visual science 63 (5), 35-35, 2022 | 4 | 2022 |
| The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration A Airody, HA Baseler, J Seymour, V Allgar, R Mukherjee, L Downey, ... Pilot and Feasibility Studies 9 (1), 63, 2023 | 2 | 2023 |
| Assessing the structure of the posterior visual pathway in bilateral macular degeneration HDH Brown, RP Gale, AD Gouws, RJW Vernon, A Airody, RLW Hanson, ... Scientific Reports 13 (1), 5008, 2023 | 2 | 2023 |
| EPDev-AI: Early phase development of an AI tool to determine disease activity in nvAMD RLW Hanson, A Airody, C O'Dwyer, A White, M Porteous, RP Gale Investigative Ophthalmology & Visual Science 63 (7), 209–F0056-209–F0056, 2022 | 1 | 2022 |
| The MATE study: Treating neovascular age-related Macular degeneration with Aflibercept: a pilot, 24 month randomised controlled trial comparing standard care with … A Airody, T Dorey, A Mankowska, K Balaskas, R Mukherjee, T Empeslidis, ... Investigative Ophthalmology & Visual Science 59 (9), 798-798, 2018 | 1 | 2018 |
| YorkMac: A binary classification, deep learning convolutional neural network detecting active neovascular age-related macular degeneration; comparing YorkMac and AutoML A Airody, R Hanson, D Hanson, C O'Dwyer, A White, S Burns, M Porteous, ... Investigative Ophthalmology & Visual Science 65 (7), 2328-2328, 2024 | | 2024 |
| Treatment of age‐related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4‐year study of treatment outcomes, durability, safety and quality of … A Airody, HA Baseler, J Seymour, V Allgar, R Mukherjee, L Downey, ... Acta ophthalmologica 102 (3), e328-e338, 2024 | | 2024 |
| Glaucoma specialist email advice service (GSEAS) R Begum, A Airody, D Venugopal, T Sohail, A Edwards, J Liput, D Burton, ... European Journal of Ophthalmology 34 (1), NP148-NP151, 2024 | | 2024 |
| An unusual case of intradural haemangioma of the optic nerve mimicking optic neuritis A Hopkins, A Airody, R Gale Acta Ophthalmologica 97, 2019 | | 2019 |
| Ocular manifestations of testicular lymphoma A Hopkins, A Airody, R Gale Acta Ophthalmologica 97, 2019 | | 2019 |
| How to set up a successful multicentre randomised controlled trial in the field of neovascular age–related macular degeneration treatment? Lessons from the MATE pilot study. A Airody, J Seymour, T Dorey, S Tom, M Aleksandra, K Balaskas, ... Investigative Ophthalmology & Visual Science 60 (9), 1168-1168, 2019 | | 2019 |
| The MATE study: a 24 month, multicentre, pilot, randomised controlled trial comparing standard care with individualised treat and extend regimen for treatment of neovascular … A Airody University of Hull and the University of York, 2019 | | 2019 |
| Functional MRI to objectively assess if the visual cortex is able to re-establish responsiveness following neovascular AMD treatment with anti-VEGF therapy R Gale, R Woodall, A Airody, A Gouws, H Baseler, A Morland Investigative Ophthalmology & Visual Science 57 (12), 4945-4945, 2016 | | 2016 |
Rachel L.W. HansonResearch Fellow in Ophthalmology | York & Scarborough Teaching Hospitals NHS Foundation Trust在 drhanson.dev 的电子邮件经过验证
